tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 og 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
olumiant
eli lilly nederland b.v. - baricitinib - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant kan anvendes som monoterapi eller i kombination med methotrexat. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
crestor 10 mg filmovertrukne tabletter
grünenthal gmbh - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
crestor 20 mg filmovertrukne tabletter
grünenthal gmbh - rosuvastatin calcium - filmovertrukne tabletter - 20 mg
crestor 40 mg filmovertrukne tabletter
grünenthal gmbh - rosuvastatin calcium - filmovertrukne tabletter - 40 mg
crestor 5 mg filmovertrukne tabletter
2care4 aps - rosuvastatin calcium - filmovertrukne tabletter - 5 mg
mitoxantron "ebewe" 2 mg/ml koncentrat til infusionsvæske, opløsning
ebewe pharma ges.m.b.h. nfg. kg - mitoxantronhydrochlorid - koncentrat til infusionsvæske, opløsning - 2 mg/ml
rosuvastatin "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 10 mg
rosuvastatin "accord" 20 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 20 mg
rosuvastatin "accord" 40 mg filmovertrukne tabletter
accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 40 mg